Search

Search Results
Results 18571 - 18580 of 18889 for breast cancer
  • Thalomid
    Drug - 23 Jan 2025
    Consumer Medicine Information (CMI) about Thalomid intended for persons living in Australia.
  • Pramin
    Drug - 21 Jan 2025
    Consumer Medicine Information (CMI) about Pramin intended for persons living in Australia.
  • An Overview of X-Linked Disorders and X Chromosome Aneuploidies
    Health - 6 Jan 2025
    Numerical abnormalities of the X chromosome, including Klinefelter’s and Turner syndromes, have significant health implications and require targeted support.
  • Types of Pathology
    Health - 20 Dec 2024
    Pathology plays a critical role in healthcare, linking scientific research to clinical practice and improving disease diagnosis and treatment strategies.
  • Pharmorubicin
    Drug - 18 Dec 2024
    Consumer Medicine Information (CMI) about Pharmorubicin intended for persons living in Australia.
  • Evotaz
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Evotaz intended for persons living in Australia.
  • Aranesp
    Drug - 2 Dec 2024
    Consumer Medicine Information (CMI) about Aranesp intended for persons living in Australia.
  • DBL Dacarbazine
    Drug - 24 Nov 2024
    Consumer Medicine Information (CMI) about DBL Dacarbazine intended for persons living in Australia.
  • Micardis Plus
    Drug - 21 Nov 2024
    Consumer Medicine Information (CMI) about Micardis Plus intended for persons living in Australia.
  • Besponsa
    Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Besponsa intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback